Solyx SIS System
Device Solyx_URO
PDI 08714729774044
General payments
$904,832
Research payments
$157,700
Through program year 2025, $904,832 in general payments and $157,700 in research payments were reported against Solyx SIS System (Solyx_URO).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $120,043 | 993 |
| 2025 | Research | $107,700 | 2 |
| 2024 | General | $245,092 | 1,267 |
| 2024 | Research | $50,000 | 1 |
| 2023 | General | $274,627 | 1,439 |
| 2022 | General | $265,070 | 1,402 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,101 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.